Cancer Letters
Volume 275, Issue 1 , Pages 44-53 , 8 March 2009

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

  • Na Li

      Affiliations

    • Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China
    • School of Life Science, Jilin University, 1260 Huoju Road, Changchun, Jilin 130012, PR China
    • ,
  • Hanjiang Fu

      Affiliations

    • Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China
    • ,
  • Yi Tie

      Affiliations

    • Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China
    • ,
  • Zheng Hu

      Affiliations

    • Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China
    • ,
  • Wei Kong

      Affiliations

    • School of Life Science, Jilin University, 1260 Huoju Road, Changchun, Jilin 130012, PR China
    • ,
  • Yongge Wu

      Affiliations

    • School of Life Science, Jilin University, 1260 Huoju Road, Changchun, Jilin 130012, PR China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 10 68214653.
    • ,
  • Xiaofei Zheng

      Affiliations

    • Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 10 68214653.

Received 10 July 2008 ,Revised 29 September 2008 ,Accepted 30 September 2008.

References 

  1. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002;31:339–346
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005;55:74–108
  3. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer. 2003;3:453–458
  4. Weigelt B, Peterse JL, van’t Veer LJ. Breast cancer metastasis: markers and models. Nat. Rev. Cancer. 2005;5:591–602
  5. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679–695
  6. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433:769–773
  7. Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene. 2006;25:6170–6175
  8. Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, et al. MicroRNA miR-199a∗ regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J. Biol. Chem. 2008;283:18158–18166
  9. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA. 2005;11:1753–1761
  10. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science. 2005;309:1519–1524
  11. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122:6–7
  12. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–86
  13. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA. 2005;102:13944–13949
  14. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839–843
  15. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120:635–647
  16. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–359
  17. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27:2128–2136
  18. Schuldt A. Micromanaging metastasis. Nat. Cell Biol. 2007;9:1121
  19. Steeg PS. Cancer: micromanagement of metastasis. Nature. 2007;499:671–673
  20. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 2008;10:202–210
  21. Musiyenko A, Bitko V, Barik S. Ectopic expression of miR-126∗, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J. Mol. Med. 2008;86:313–322
  22. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147–152
  23. Lin SL, Chiang A, Chang D, Ying SY. Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 2008;14:417–424
  24. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA. 2008;105:5874–5878
  25. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007;17:1298–1307
  26. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130–1134
  27. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007;26:5017–5022
  28. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell. 2007;26:745–752
  29. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA. 2007;104:15472–15477
  30. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008;582:1564–1568
  31. Hermeking H. p53 enters the microRNA world. Cancer Cell. 2007;12:414–418
  32. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, et al. The MYCN oncogene is a direct target of miR-34a. Oncogene. 2008;Epub ahead of print
  33. Leelawat K, Leelawat S, Tepaksorn P, Rattanasinganchan P, Leungchaweng A, Tohtong R, et al. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. J. Surg. Res. 2006;136:78–84
  34. Ma PC, Tretiakova MS, Nallasura V, Jagadeeswaran R, Husain AN, Salgia R, et al. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion. Br. J. Cancer. 2007;97:368–377
  35. Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways DK, et al. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cell. Signal. 1999;11:885–890
  36. Wang ZL, Liang P, Dong BW, Yu XL, Yu DJ. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J. Gastrointest. Surg. 2008;12:327–337
  37. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008;Epub ahead of print
  38. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA. 2004;101:11755–11760
  39. Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y, et al. Hepatocyte growth factor, transforming growth factor a, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol. Carcinog. 2003;36:130–141
  40. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008;47:897–907
  41. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell. 2007;26:731–743

PII: S0304-3835(08)00804-5

doi: 10.1016/j.canlet.2008.09.035

Cancer Letters
Volume 275, Issue 1 , Pages 44-53 , 8 March 2009

Article Tools

* Image Usage & Resolution